Related Experiment Video
Updated: Sep 24, 2025

An “All-laser” Endothelial Transplant
Published on: July 6, 2015
Fine-needle diathermy for corneal vascularisation
Swetha Ravichandran1, Radhika Natarajan1
1Department of Cornea and Refractive Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Fine Needle Diathermy (FND) effectively treats corneal neovascularization by occluding blood vessels. This procedure is best for mature vessels and may improve outcomes before corneal transplantation.
Area of Science:
- Ophthalmology
- Regenerative Medicine
Background:
- Corneal angiogenesis, a response to injury, involves immune cells and toxin removal but causes vision impairment.
- Neovascularization leads to lipid keratopathy and immunogenicity, often necessitating treatment before keratoplasty.
Purpose of the Study:
- To demonstrate the Fine Needle Diathermy (FND) procedure for treating corneal neovascularization.
- To outline the indications and contraindications for using FND in corneal vascularization.
Main Methods:
- FND utilizes monopolar cautery to coagulate afferent and efferent corneal blood vessels.
- The technique involves precise needle placement, targeting mature vessels while avoiding necrotic tissue.
Main Results:
- FND is most effective during the mature vessel formation stage of corneal neovascularization.
- The procedure is particularly beneficial for neovascularization resulting from infectious keratitis.
Conclusions:
- Fine Needle Diathermy is a viable treatment for corneal neovascularization.
- Optimal timing for keratoplasty is 3-4 months post-FND, after vascular regression.
More Related Videos
06:23Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss
Published on: April 24, 2020
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...